We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fluorescent Carbon Nanotubes Accurately Detect Bacteria and Viruses

By LabMedica International staff writers
Posted on 31 Jul 2023

An interdisciplinary research team that comprised scientists from Ruhr University Bochum (RUB, Bochum, Germany) has developed an innovative method to construct modular optical sensors capable of identifying viruses and bacteria. The team utilized fluorescent carbon nanotubes attached to a novel type of DNA anchors which serve as molecular handles. These anchor structures can be utilized to conjugate biological recognition units such as antibodies aptamers to the nanotubes, enabling interaction with bacterial or viral molecules. This interaction impacts the fluorescence of the nanotubes, causing their brightness levels to increase or decrease.

The research team utilized tubular nanosensors composed of carbon, each with a diameter of less than one nanometer. When irradiated with visible light, these nanotubes emit near-infrared light, a spectrum invisible to the human eye but ideal for optical applications due to the significant reduction of other signals within this range. Previously, the team had successfully manipulated the nanotubes' fluorescence to detect vital biomolecules. Their latest effort involved customizing carbon sensors for easy detection of various target molecules.

This breakthrough was achieved with the help of DNA structures with guanine quantum defects. This process involved linking DNA bases to the nanotube in order to introduce a defect into the nanotube's crystal structure. Consequently, the nanotubes' fluorescence underwent a quantum-level change. In addition, the defect functioned as a molecular handle, enabling the addition of a detection unit that could be adjusted to the respective target molecule to identify a specific viral or bacterial protein.

The team demonstrated the new sensor concept by targeting the SARS-CoV-2 spike protein. Researchers used aptamers that bind to the SARS-CoV-2 spike protein, following which the fluorescent sensors reliably indicated the protein's presence. Notably, the selectivity and stability of sensors featuring guanine quantum defects surpassed those of sensors without such defects, especially when in solution.

Related Links:
Ruhr University Bochum

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.